Developer docs
API playgroundTry for free, no card

Search company profiles

STREX

Full company profile

uuid000eo2x

Namestring
STREX
Legal namestring
ストレックス株式会社
Websiteurl
strex.co.jp
Company typeenum
Private
Founded yearint
2003
Descriptiontext

STREX Co., Ltd. (ストレックス株式会社) is a privately held Japanese medical research equipment manufacturer founded in 2003 and headquartered in Osaka, Japan. The company develops and sells specialized laboratory instruments for cell biology research, with a product portfolio organized around three core capability areas: controlled-rate cryopreservation, mechanical stimulation of cells (gas pressure and stretching), and vacuum plasma surface treatment. Its flagship product, the CytoSAVER Programmable Freezer FZ Series, uses proprietary Stirling cooler technology to perform LN2-free controlled-rate freezing — an architecture developed in response to a request from the Kyoto University iPS Research Institute (京都大学iPS研究所) for use inside Cell Processing Facilities (CPF). The freezer line spans FZ-2100 through FZ-3400 models, with FDA Title 21 CFR Part 11 (cGMP)-compliant variants (FZ-2200, FZ-3200) for pharmaceutical and clinical applications. The mechanobiology line includes the SP Series gas pressure stimulators (120–300 mmHg) and the ST Series cell stretching systems in manual, automated (ST-1400, ST-1440), microscope-mountable (ST-1500), and biaxial (ST-1900) configurations, supported by a range of PDMS-based stretch chambers as accessories. The SL-0600 vacuum plasma cleaner addresses surface activation, cleaning, and PDMS bonding for cell culture and microfluidic device fabrication.

STREX sells directly to research institutions, universities, and biotechnology companies in Japan and internationally, offering free demonstrations and technical consultation as part of an enterprise field-sales motion. The company markets through its corporate website (strex.co.jp domestic; strexcell.com English-language international site), content marketing via case studies and technical libraries, and an inquiry-based demo request channel. Revenue is generated primarily through one-time hardware sales under a quote-based pricing model, with a recurring-revenue adjacency from consumable stretch chambers and accessories. The primary customer segments are research institutions and universities (cell biology, regenerative medicine, stem cell and iPS research) and Cell Processing Facilities requiring GMP-compliant cryopreservation. A secondary segment comprises biotechnology and medical device companies using plasma treatment for biochip and microfluidic device fabrication. STREX has no disclosed venture capital, private equity, or institutional ownership and operates as an independent corporation.

The company's competitive position rests on three proprietary technology pillars — Stirling cooler-based LN2-free freezing, multi-pattern mechanical cell stimulation, and benchtop vacuum plasma treatment — combined with a documented regulatory moat (FDA 21 CFR Part 11 compliance on clinical models) and an ongoing U.S. patent application (No. 15/872,157) covering cardiocyte cryopreservation methods. Its strategic anchor is the co-development partnership with Kyoto University iPS Research Institute, which has shaped the CPF-compatible CytoSAVER roadmap and provided the company with credibility in the regenerative medicine research community. The most recent strategic signals — international site launch, U.S. patent filing, and FDA-compliant clinical variants — indicate a measured push from Japanese academic research buyers into regulated international cell-therapy manufacturing customers.

Short descriptiontext

STREX (ストレックス株式会社) is a privately held Osaka-based manufacturer of specialized medical research equipment, serving universities, research institutions, and Cell Processing Facilities with LN2-free programmable freezers, cell stretching and gas-pressure stimulation systems, and vacuum plasma surface treatment devices for cell biology, regenerative medicine, and stem-cell research.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersOsaka, Japan
HQ citystring
Osaka
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical research equipment, programmable freezers, cell stretching systems, vacuum plasma cleaners, laboratory instruments
Industry2 codes
PRIMARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Medical Research Equipment
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Research Equipment Sales
TypeHardware Sales
Description

Sale of specialized laboratory equipment including programmable freezers, cell stretching systems, gas pressure stimulators, and plasma treatment devices. Revenue is generated through one-time hardware sales with potential for accessories and consumables.

strex.co.jp
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details1 tier
1Custom quotation-based pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing available upon inquiry. The company offers free demonstrations and technical consultations to help customers select appropriate products for their research needs.

strex.co.jp
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

STREX develops and manufactures specialized medical research equipment for cell biology applications. Its product portfolio includes LN2-free programmable controlled-rate freezers (CytoSAVER FZ Series), automated and manual cell stretching systems (ST Series), gas pressure stimulators (SP Series), and vacuum plasma cleaners (SL-0600). Equipment is sold primarily to universities, research institutes, cell processing facilities, and biotechnology companies for regenerative medicine, stem cell, and mechanobiology research.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • CytoSAVER used in multiple peer-reviewed scientific publications including stem cell and iPS cell research
Product overview1 text field

STREX (ストレックス株式会社) develops and manufactures medical research equipment, primarily focusing on cell biology and cryopreservation instruments. The product portfolio consists of three core lines: (1) CytoSAVER Programmable Freezer FZ Series - LN2-free controlled-rate freezers using Stirling cooler technology for stem cells, cord blood, and IVF samples; (2) Cell Stimulation Systems including gas pressure stimulators (SP Series) and cell stretching systems (ST Series) available in manual, automated, and microscope-mountable configurations for mechanobiology research; (3) Vacuum Plasma Cleaner SL-0600 for surface treatment and PDMS bonding. The products support regenerative medicine research, cell therapy, and pharmaceutical development across universities and research institutions.

Product and service8 records
1CytoSAVER Programmable Freezer FZ Series
CategoryProgrammable Freezers
Description

LN2-free programmable freezer for controlled-rate cell cryopreservation using Stirling cooler technology. Supports stem cells, cord blood, and IVF samples with precise cooling rate control. Available in FZ-2100/2200/3100/3200/3400 models, with FZ-2200 and FZ-3200 models compliant with FDA 21 CFR Part 11 for pharmaceutical and clinical applications.

2Gas Pressure Stimulator SP Series
CategoryMechanical Stimulation Equipment
Description

Mechanical stress stimulation system that applies gas pressure (120-300mmHg) to cells for mechanobiology research. Features continuous and intermittent pressure modes, suitable for vascular endothelial cells, cardiac cells, kidney cells, and retinal neurons.

3Vacuum Plasma Cleaner SL-0600
CategoryPlasma Treatment Equipment
Description

Benchtop vacuum plasma treatment device for surface cleaning, activation, and modification of materials. Used for PDMS bonding, cell culture surface preparation, and improving adhesion of coatings.

4Automated Cell Stretching System ST-1400/ST-1440
CategoryCell Stretching Systems
Description

Automated stretching device for applying mechanical stretch stimuli to cells inside a CO2 incubator. ST-1400 (10cc) holds 6 chambers; ST-1440 (4cc) holds 8 chambers simultaneously for comparative studies.

5Manual Cell Stretching System ST-0040/ST-0100
CategoryCell Stretching Systems
Description

Manual cell stretching device for trial experiments before investing in automated systems, used for stretch/compression applications in mechanobiology research.

6Microscope Mountable Cell Stretching System ST-1500
CategoryCell Stretching Systems
Description

Bilateral cell stretching system designed for microscope mounting, allowing continuous observation of single cells without removing them from the field of view.

7Biaxial Cell Stretching System ST-1900
CategoryCell Stretching Systems
Description

Microscope-mountable biaxial stretching system capable of applying stretch and compression in two axes for comprehensive mechanobiology studies.

8Cell Thawing Device YS Series
CategoryCell Thawing Equipment
Description

Water-free cell thawing device for use in cleanrooms and CPF facilities, with a compact design that allows operation inside biosafety cabinets.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Development partnership for creating a programmable freezer compatible with cell processing facility (CPF) requirements. The collaboration resulted in the development of the LN2-free CytoSAVER series specifically designed for cleanroom environments in regenerative medicine facilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialist in cell and gene therapy cryopreservation, offering controlled-rate freezers, storage systems, and cryopreservation media. Directly comparable to STREX's CytoSAVER line and the same iPS/cell-therapy CPF customer base.

TypeBroad incumbent
Description

Large-scale life sciences tools provider with broad cell culture, bioprocessing, and cell-therapy manufacturing equipment. Overlaps with STREX in cell processing and cryopreservation workflows but as part of a much wider product portfolio.

TypeDirect peer
Description

Supplies cell processing instruments, reagents, and devices for cell therapy and regenerative medicine. Closely aligned with STREX in CPF equipment, particularly around GMP-compliant cell handling.

TypeBroad incumbent
Description

Dominant global lab equipment and life sciences tools company, including controlled-rate freezers (e.g., Thermo Series) and cell culture instrumentation. Overlaps with all four STREX product lines as a broad incumbent rather than a niche specialist.

TypeBroad incumbent
Description

Established lab equipment manufacturer (bioreactors, cell handling, consumables). Adjacent to STREX in cell culture instrumentation and serves overlapping academic and biotech customers.

TypeDirect peer
Description

Specialty provider of cell culture media, instruments, and protocols for stem cell and regenerative medicine research. Highly comparable to STREX in customer base (iPS/stem cell labs) and product type (cell processing tools).

TypeBroad incumbent
Description

Global cell and gene therapy manufacturing services and equipment provider, including process development tools for CPFs. Overlaps with STREX on the cell therapy manufacturing equipment side and shares large pharma/biotech customers.

TypeBroad incumbent
Description

Bioprocessing and cell therapy equipment manufacturer serving pharma and academic customers. Comparable to STREX in cell processing instrumentation but operates at a much larger scale and product breadth.

TypeEmerging player
Description

Manufactures precision lab automation, sample storage, and cell processing instruments. Overlaps with STREX in automated cell handling and storage for research and clinical applications.

TypeDirect peer
Description

Provider of automated sample storage, cryogenic storage systems, and biostorage services. Directly comparable to STREX's controlled-rate freezing franchise, particularly for high-value biological sample preservation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

STREX

Medical Research Equipmentstrex.co.jp

STREX (ストレックス株式会社) is a privately held Osaka-based manufacturer of specialized medical research equipment, serving universities, research institutions, and Cell Processing Facilities with LN2-free programmable freezers, cell stretching and gas-pressure stimulation systems, and vacuum plasma surface treatment devices for cell biology, regenerative medicine, and stem-cell research.

What STREX does

STREX Co., Ltd. (ストレックス株式会社) is a privately held Japanese medical research equipment manufacturer founded in 2003 and headquartered in Osaka, Japan. The company develops and sells specialized laboratory instruments for cell biology research, with a product portfolio organized around three core capability areas: controlled-rate cryopreservation, mechanical stimulation of cells (gas pressure and stretching), and vacuum plasma surface treatment. Its flagship product, the CytoSAVER Programmable Freezer FZ Series, uses proprietary Stirling cooler technology to perform LN2-free controlled-rate freezing — an architecture developed in response to a request from the Kyoto University iPS Research Institute (京都大学iPS研究所) for use inside Cell Processing Facilities (CPF). The freezer line spans FZ-2100 through FZ-3400 models, with FDA Title 21 CFR Part 11 (cGMP)-compliant variants (FZ-2200, FZ-3200) for pharmaceutical and clinical applications. The mechanobiology line includes the SP Series gas pressure stimulators (120–300 mmHg) and the ST Series cell stretching systems in manual, automated (ST-1400, ST-1440), microscope-mountable (ST-1500), and biaxial (ST-1900) configurations, supported by a range of PDMS-based stretch chambers as accessories. The SL-0600 vacuum plasma cleaner addresses surface activation, cleaning, and PDMS bonding for cell culture and microfluidic device fabrication.

STREX sells directly to research institutions, universities, and biotechnology companies in Japan and internationally, offering free demonstrations and technical consultation as part of an enterprise field-sales motion. The company markets through its corporate website (strex.co.jp domestic; strexcell.com English-language international site), content marketing via case studies and technical libraries, and an inquiry-based demo request channel. Revenue is generated primarily through one-time hardware sales under a quote-based pricing model, with a recurring-revenue adjacency from consumable stretch chambers and accessories. The primary customer segments are research institutions and universities (cell biology, regenerative medicine, stem cell and iPS research) and Cell Processing Facilities requiring GMP-compliant cryopreservation. A secondary segment comprises biotechnology and medical device companies using plasma treatment for biochip and microfluidic device fabrication. STREX has no disclosed venture capital, private equity, or institutional ownership and operates as an independent corporation.

The company's competitive position rests on three proprietary technology pillars — Stirling cooler-based LN2-free freezing, multi-pattern mechanical cell stimulation, and benchtop vacuum plasma treatment — combined with a documented regulatory moat (FDA 21 CFR Part 11 compliance on clinical models) and an ongoing U.S. patent application (No. 15/872,157) covering cardiocyte cryopreservation methods. Its strategic anchor is the co-development partnership with Kyoto University iPS Research Institute, which has shaped the CPF-compatible CytoSAVER roadmap and provided the company with credibility in the regenerative medicine research community. The most recent strategic signals — international site launch, U.S. patent filing, and FDA-compliant clinical variants — indicate a measured push from Japanese academic research buyers into regulated international cell-therapy manufacturing customers.

STREX firmographics

Firmographics
Name
STREX
Legal name
ストレックス株式会社
Website
https://strex.co.jp
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
101–250 employees
Short description
STREX (ストレックス株式会社) is a privately held Osaka-based manufacturer of specialized medical research equipment, serving universities, research institutions, and Cell Processing Facilities with LN2-free programmable freezers, cell stretching and gas-pressure stimulation systems, and vacuum plasma surface treatment devices for cell biology, regenerative medicine, and stem-cell research.
Ownership category
akta.pro rank

STREX industry classification

Industry
Product category
Medical Research Equipment
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)

Keywords

  • Medical research equipment
  • Programmable freezers
  • Cell stretching systems
  • Vacuum plasma cleaners
  • Laboratory instruments

Where STREX is headquartered

Location

Headquarters

HQ city
Osaka
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

STREX business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Medical Research Equipment Sales: Sale of specialized laboratory equipment including programmable freezers, cell stretching systems, gas pressure stimulators, and plasma treatment devices. Revenue is generated through one-time hardware sales with potential for accessories and consumables.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goCustom quotation-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

STREX product offering

Product offering

Core offering

STREX develops and manufactures specialized medical research equipment for cell biology applications. Its product portfolio includes LN2-free programmable controlled-rate freezers (CytoSAVER FZ Series), automated and manual cell stretching systems (ST Series), gas pressure stimulators (SP Series), and vacuum plasma cleaners (SL-0600). Equipment is sold primarily to universities, research institutes, cell processing facilities, and biotechnology companies for regenerative medicine, stem cell, and mechanobiology research.

Product overview

STREX (ストレックス株式会社) develops and manufactures medical research equipment, primarily focusing on cell biology and cryopreservation instruments. The product portfolio consists of three core lines: (1) CytoSAVER Programmable Freezer FZ Series - LN2-free controlled-rate freezers using Stirling cooler technology for stem cells, cord blood, and IVF samples; (2) Cell Stimulation Systems including gas pressure stimulators (SP Series) and cell stretching systems (ST Series) available in manual, automated, and microscope-mountable configurations for mechanobiology research; (3) Vacuum Plasma Cleaner SL-0600 for surface treatment and PDMS bonding. The products support regenerative medicine research, cell therapy, and pharmaceutical development across universities and research institutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • CytoSAVER Programmable Freezer FZ Series LN2-free programmable freezer for controlled-rate cell cryopreservation using Stirling cooler technology. Supports stem cells, cord blood, and IVF samples with precise cooling rate control. Available in FZ-2100/2200/3100/3200/3400 models, with FZ-2200 and FZ-3200 models compliant with FDA 21 CFR Part 11 for pharmaceutical and clinical applications.
  • Gas Pressure Stimulator SP Series Mechanical stress stimulation system that applies gas pressure (120-300mmHg) to cells for mechanobiology research. Features continuous and intermittent pressure modes, suitable for vascular endothelial cells, cardiac cells, kidney cells, and retinal neurons.
  • Vacuum Plasma Cleaner SL-0600 Benchtop vacuum plasma treatment device for surface cleaning, activation, and modification of materials. Used for PDMS bonding, cell culture surface preparation, and improving adhesion of coatings.
  • Automated Cell Stretching System ST-1400/ST-1440 Automated stretching device for applying mechanical stretch stimuli to cells inside a CO2 incubator. ST-1400 (10cc) holds 6 chambers; ST-1440 (4cc) holds 8 chambers simultaneously for comparative studies.
  • Manual Cell Stretching System ST-0040/ST-0100 Manual cell stretching device for trial experiments before investing in automated systems, used for stretch/compression applications in mechanobiology research.
  • Microscope Mountable Cell Stretching System ST-1500 Bilateral cell stretching system designed for microscope mounting, allowing continuous observation of single cells without removing them from the field of view.
  • Biaxial Cell Stretching System ST-1900 Microscope-mountable biaxial stretching system capable of applying stretch and compression in two axes for comprehensive mechanobiology studies.
  • Cell Thawing Device YS Series Water-free cell thawing device for use in cleanrooms and CPF facilities, with a compact design that allows operation inside biosafety cabinets.

Quantifiable outcome

  • CytoSAVER used in multiple peer-reviewed scientific publications including stem cell and iPS cell research

Companies that use STREX

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

STREX technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

STREX partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Kyoto University iPS Research InstitutecoreStrategic or Co-development PartnerDevelopment partnership for creating a programmable freezer compatible with cell processing facility (CPF) requirements. The collaboration resulted in the development of the LN2-free CytoSAVER series specifically designed for cleanroom environments in regenerative medicine facilities.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

STREX competitors and assessment

Company assessment

Direct peers

  • BioLife Solutions: Specialist in cell and gene therapy cryopreservation, offering controlled-rate freezers, storage systems, and cryopreservation media. Directly comparable to STREX's CytoSAVER line and the same iPS/cell-therapy CPF customer base.
  • Miltenyi Biotec: Supplies cell processing instruments, reagents, and devices for cell therapy and regenerative medicine. Closely aligned with STREX in CPF equipment, particularly around GMP-compliant cell handling.
  • STEMCELL Technologies: Specialty provider of cell culture media, instruments, and protocols for stem cell and regenerative medicine research. Highly comparable to STREX in customer base (iPS/stem cell labs) and product type (cell processing tools).
  • Brooks Life Sciences: Provider of automated sample storage, cryogenic storage systems, and biostorage services. Directly comparable to STREX's controlled-rate freezing franchise, particularly for high-value biological sample preservation.

Broad incumbents

  • Cytiva (Danaher): Large-scale life sciences tools provider with broad cell culture, bioprocessing, and cell-therapy manufacturing equipment. Overlaps with STREX in cell processing and cryopreservation workflows but as part of a much wider product portfolio.
  • Thermo Fisher Scientific: Dominant global lab equipment and life sciences tools company, including controlled-rate freezers (e.g., Thermo Series) and cell culture instrumentation. Overlaps with all four STREX product lines as a broad incumbent rather than a niche specialist.
  • Eppendorf: Established lab equipment manufacturer (bioreactors, cell handling, consumables). Adjacent to STREX in cell culture instrumentation and serves overlapping academic and biotech customers.
  • Lonza: Global cell and gene therapy manufacturing services and equipment provider, including process development tools for CPFs. Overlaps with STREX on the cell therapy manufacturing equipment side and shares large pharma/biotech customers.
  • Sartorius: Bioprocessing and cell therapy equipment manufacturer serving pharma and academic customers. Comparable to STREX in cell processing instrumentation but operates at a much larger scale and product breadth.

Emerging players

  • Hamilton Company: Manufactures precision lab automation, sample storage, and cell processing instruments. Overlaps with STREX in automated cell handling and storage for research and clinical applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

STREX compliance and trust

Trust signal

Compliance1 record

STREX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

STREX leadership team

Management profile

Number of profiles

Profiles2 records

STREX funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

STREX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STREX

What does STREX do?

STREX develops and manufactures specialized medical research equipment for cell biology applications. Its product portfolio includes LN2-free programmable controlled-rate freezers (CytoSAVER FZ Series), automated and manual cell stretching systems (ST Series), gas pressure stimulators (SP Series), and vacuum plasma cleaners (SL-0600). Equipment is sold primarily to universities, research institutes, cell processing facilities, and biotechnology companies for regenerative medicine, stem cell, and mechanobiology research.

Is STREX a public or private company?

STREX is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was STREX founded?

STREX was founded in 2003. It employs 101 to 250 people.

Where is STREX based?

STREX is headquartered in Osaka, Japan, in the Asia region.

How does STREX make money?

One revenue line is on record: medical Research Equipment Sales.

Who are STREX's main competitors?

Direct peers on record are BioLife Solutions, Miltenyi Biotec, STEMCELL Technologies and Brooks Life Sciences. Broad incumbents are Cytiva (Danaher), Thermo Fisher Scientific, Eppendorf, Lonza and Sartorius. Hamilton Company is listed as an emerging player.

Does STREX have an API?

No public API is recorded for STREX.

What industry is STREX in?

STREX's product category is Medical Research Equipment. Its primary akta.pro industry code is HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales